Clinical Trials for Sirtex Medical

Explore 7 clinical trials worldwide

Showing 1-7 of 7 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Sirtex Medical

Clinical Trials (7)

NCT06555133
Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC
PHASE2Recruiting
18 participants
Started: Apr 7, 2025 · Completed: Sep 1, 2029
1 condition3 sponsors1 location
NCT05655949
Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio
PHASE2Recruiting
30 participants
Started: Feb 13, 2024 · Completed: Dec 1, 2027
5 conditions4 sponsors1 location
NCT05967143
Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)
N/ARecruiting
845 participants
Started: Jun 19, 2023 · Completed: Jun 30, 2029
2 conditions1 sponsor9 locations
NCT05701488
SIRT With Tremelimumab and Durvalumab for Resectable HCC
PHASE1Recruiting
20 participants
Started: Apr 21, 2023 · Completed: Oct 1, 2026
3 conditions3 sponsors3 locations
NCT05195710
Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases
PHASE1Recruiting
50 participants
Started: Nov 16, 2022 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT05377034
Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients
PHASE2Recruiting
100 participants
Started: Oct 26, 2022 · Completed: Jan 31, 2028
1 condition4 sponsors14 locations
NCT04736121
Selective Internal Radiation Therapy (SIRT) Using SIR-Spheres® Y-90 Resin Microspheres on DoR & ORR in Unresectable Hepatocellular Carcinoma Patients
NAActive, not recruiting
100 participants
Started: May 28, 2021 · Completed: Dec 31, 2026
4 conditions2 sponsors22 locations